Vitamin E and Alzheimer's disease: what do we know so far?

Area of Science:

• Neuroscience
• Nutritional Science
• Gerontology

Background:

• Vitamin E, including tocopherols and tocotrienols, possesses antioxidant, anti-inflammatory, and cholesterol-lowering properties.
• Reduced vitamin E levels are observed in Alzheimer's disease (AD) patients and linked to increased AD risk.
• Dietary vitamin E intake may slow AD progression, potentially through synergistic effects with other micronutrients.

Purpose of the Study:

• To evaluate the potential of vitamin E as a clinical intervention for Alzheimer's disease (AD).
• To explore the biological rationale and clinical evidence supporting vitamin E's role in AD.
• To identify factors contributing to the inconclusive findings of vitamin E supplementation in AD.

Main Methods:

• Review of existing literature on vitamin E's biological functions and its association with AD.
• Analysis of findings from randomized controlled trials (RCTs) investigating vitamin E supplementation for AD.
• Consideration of factors influencing vitamin E bioavailability, activity, and clinical response.

Main Results:

• A strong theoretical basis exists for vitamin E's benefit in AD due to its biological functions.
• Randomized trials have yielded limited and inconsistent evidence for vitamin E supplementation efficacy in AD.
• Individual genetic variations may affect vitamin E's biological activity and clinical responsiveness.

Conclusions:

• Despite a plausible biological rationale, the clinical evidence for vitamin E in treating AD remains inconclusive.
• Methodological limitations in trials and individual genetic variability may explain the inconsistent results.
• Further research is needed to clarify the role of vitamin E in AD and its clinical safety.